Atezolizumab plus carboplatin and nab-paclitaxel versus carboplatin and nab-paclitaxel as treatments for Chinese, treatment-naive, stage IV, non-squamous, non-small-cell lung cancer patients: A retrospective analysis

Chen, YK; Kang, SZ; Yan, M

Yan, M (通讯作者),Peoples Hosp Rongchang Dist, Dept Resp & Crit Care Med, Chongqing 402460, Peoples R China.

PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022; 10 (3):

Abstract

The IMpower trials reported significant effects of atezolizumab-containing chemotherapies on Caucasian patients. Chinese patients differ from their We......

Full Text Link